MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-DL-02-0050470
Reliwand Pharmaceutical Private Limited
Reliwand Pharmaceutical Private Limited - pharma in Delhi, India. Directors, charges & compliance details.
Revenue · FY 2024
₹9.98 Lakh
Latest filing
Net loss · FY 2024
₹10.83 Lakh
Net margin -108.6%
EBITDA · FY 2024
-₹10.71 Lakh
EBITDA margin -107.3%
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Open charges
₹25 Lakh
Secured borrowings
Company age
3 yrs
Est. 2023
Directors on board
2
As per MCA filings
About Reliwand Pharmaceutical Private Limited
Data last updated:
Reliwand Pharmaceutical Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 20 January 2023.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24299DL2023PTC410202.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Satish Kumar and Arti Pandey.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 2 – A/3 Kundan Mansion Asaf Ali Road Turkman Gate New Delhi, Delhi, India – 110002.
As per the financials filed for FY 2024, the company reported a revenue of ₹9.98 Lakh. For the same year it recorded a net loss of ₹10.83 Lakh (net margin -108.6%) and EBITDA of -₹10.71 Lakh (EBITDA margin -107.3%).
As per MCA filings, the company has open charges of ₹25 Lakh on record.
Reliwand Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-02-0050470). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24299DL2023PTC410202
Registration Number 410202
Incorporation Date 20 January 2023
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-02-0050470
Recognitions & Rankings of Reliwand Pharmaceutical
Contact details
Reliwand Pharmaceutical Private Limited's registered office is in Delhi, Delhi.
- Registered Address2 – A/3 Kundan Mansion Asaf Ali Road Turkman Gate New Delhi, Delhi, India – 110002
- IndustryPharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Reliwand Pharmaceutical Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Reliwand Pharmaceutical is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale and retail trade and repair of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 45 | Wholesale and retail trade and repair of motor vehicles and motorcycles |
To see the full business activity and turnover split of Reliwand Pharmaceutical Private Limited, buy the company report.
Financials of Reliwand Pharmaceutical Private Limited
FY 2025 filings availableReliwand Pharmaceutical Private Limited reported revenue of ₹9.98 Lakh for FY 2024.
Revenue · FY 2024
₹9.98 Lakh
Net loss · FY 2024
₹10.83 Lakh margin -108.6%
EBITDA · FY 2024
-₹10.71 Lakh margin -107.3%
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | -₹10.71 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | -₹10.83 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -107.3% | |
| Net Profit Margin | -108.6% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Reliwand Pharmaceutical Private Limited, buy the company report.
Board of directors of Reliwand Pharmaceutical Private Limited
Reliwand Pharmaceutical has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Satish Kumar | Director | 20 Jan 2023 | 3 Years 9 Months | Current |
| Arti Pandey | Additional Director | 20 Apr 2023 | 3 Years 6 Months | Current |
Peer comparison
Reliwand Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale and retail trade and repair of motor vehicles and motorcycles), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Kok 2 Atiya Ventures Private Limited | ₹10.02 Lakh (FY 2025) | -15.0% | Thoubal, Manipur, India | |||
| Uvisky India Private Limited | ₹10.01 Lakh (FY 2024) | -67.0% | Delhi, India | |||
| Kameshwar Singh Agri and Service Private Limited | ₹10 Lakh (FY 2024) | Sasaram, Bihar, India | ||||
| Ambica Tradexpo Private Limited | ₹10 Lakh (FY 2025) | New Delhi, Delhi, India | ||||
| BCL Engineers Private Limited | ₹9.99 Lakh (FY 2025) | -52.0% | New Delhi, Delhi, India | |||
| Reliwand Pharmaceutical Private Limitedthis company | ₹9.98 Lakh (FY 2024) | -₹10.83 Lakh | -108.6% | Delhi, India | ||
| Tribhuvan Investment Consultancy Services Private Limited | ₹9.95 Lakh (FY 2025) | 19.0% | Kolkata, West Bengal, India | |||
| M Manas Jewels Private Limited | ₹9.95 Lakh (FY 2025) | -47.0% | Jaipur, Rajasthan, India | |||
| Adijay Enterprises Private Limited | ₹9.95 Lakh (FY 2024) | Bhubaneswar, Odisha, India | ||||
| L&M Green Infra Limited | ₹9.94 Lakh (FY 2025) | 271.0% | Chennai, Tamil Nadu, India | |||
| Hreal Private Limited | ₹9.92 Lakh (FY 2025) | -24.0% | Pune, Maharashtra, India |
To see the full peer comparison of Reliwand Pharmaceutical Private Limited, buy the company report.
Charges & borrowings
Open charges
₹25 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Dec 2023 | 100849840 | Others | ₹25 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Reliwand Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Reliwand Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Reliwand Pharmaceutical Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Reliwand Pharmaceutical Private Limited has 4 board changes on record since 2023: 3 appointments and 1 cessation. The latest: Arti Pandey was appointed as Additional Director on 20 Apr 2023.
AGM
Reliwand Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Reliwand Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I.
Charges
A charge with Others amounted to Rs. 25.00 Lakh with Charge ID 100849840 was registered on 27 Dec 2023.
Appointed
Arti Pandey was appointed as Additional Director.
Ceased
Ashok Kumar Pande ceased to be Director.
Appointed
Ashok Kumar Pande was appointed as Director.
Appointed
Satish Kumar was appointed as Director.
Incorporation
20 Jan 2023
Reliwand Pharmaceutical Private Limited was registered on 20 Jan 2023 with Roc Delhi I & aged 3 years 9 months as per MCA records.
Frequently asked questions
Reliwand Pharmaceutical is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 20 January 2023 (3+ years old) and is registered under CIN U24299DL2023PTC410202.
Reliwand Pharmaceutical has 2 current directors:
- Satish Kumar - Director
- Arti Pandey - Additional Director
The latest financial statements of Reliwand Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Reliwand Pharmaceutical is U24299DL2023PTC410202. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Reliwand Pharmaceutical was incorporated on 20 January 2023, making it 3+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Reliwand Pharmaceutical by revenue are Kok 2 Atiya Ventures Private Limited, Uvisky India Private Limited, Kameshwar Singh Agri and Service Private Limited, Ambica Tradexpo Private Limited, BCL Engineers Private Limited and 5 more, all in the same principal business activity (wholesale and retail trade and repair of motor vehicles and motorcycles).
Arti Pandey was appointed as Additional Director on 20 Apr 2023. Ashok Kumar Pande ceased to be Director on 20 Apr 2023. Ashok Kumar Pande was appointed as Director on 20 Jan 2023. Reliwand Pharmaceutical has 4 board changes on record in total.
Yes, Reliwand Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-02-0050470).
The registered office of Reliwand Pharmaceutical is at 2 – A3 Kundan Mansion Asaf Ali Road Turkman Gate New Delhi, Delhi, India – 110002.
Reliwand Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Reliwand Pharmaceutical has open charges of ₹25 Lakh and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages